A Multinational, Multi-center, Randomized, Double-blind, Active Comparator, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Donepezil Transdermal Patch in Patients With Alzheimer's Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

399

Participants

Timeline

Start Date

October 12, 2017

Primary Completion Date

July 3, 2020

Study Completion Date

July 20, 2020

Conditions
Alzheimer Disease
Interventions
DRUG

Donepezil patch

Treatment

DRUG

aricept Tab

Comparator

Trial Locations (1)

Unknown

46 Sites including Konkuk University Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Icure Pharmaceutical Inc.

INDUSTRY

NCT03197740 - A Multinational, Multi-center, Randomized, Double-blind, Active Comparator, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Donepezil Transdermal Patch in Patients With Alzheimer's Disease | Biotech Hunter | Biotech Hunter